- Filed
- Feb 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Dec 31, 2025 | 3.64M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2025 | 3.46M sh |
| Shares Diluted restated | Q3 2025 · Dec 31, 2024 | 3.29M sh |
| Shares Diluted restated | Q3 2025 · Dec 31, 2024 | 3.28M sh |
| Capex | Q3 2025 · Dec 31, 2025 | $58K |
| Capex | Q3 2025 · Dec 31, 2024 | $48K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2025 | $407K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2024 | $1.3M |
| Long Term Debt | Q3 2025 · Dec 31, 2025 | $9.04M |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $9.97M |
| Short Term Debt | Q3 2025 · Dec 31, 2025 | $803K |
| Short Term Debt | Q3 2025 · Mar 31, 2025 | $353K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2025 | $4.72M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $5.97M |
| Stockholders Equity | Q3 2025 · Dec 31, 2025 | $11.84M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $11.38M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $10.81M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $11.88M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $14.48M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $15.8M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $19.08M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $22.54M |
| Current Liabilities | Q3 2025 · Dec 31, 2025 | $24.23M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $26.84M |
| Total Liabilities | Q3 2025 · Dec 31, 2025 | $36.41M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $40.58M |
| Current Assets | Q3 2025 · Dec 31, 2025 | $32.8M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $35.5M |
| Total Assets | Q3 2025 · Dec 31, 2025 | $48.25M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $52.46M |
| Eps Diluted | Q3 2025 · Dec 31, 2025 | $0.04 |
| Eps Diluted | Q3 2025 · Dec 31, 2025 | −$0.48 |
| Eps Diluted restated | Q3 2025 · Dec 31, 2024 | −$0.46 |
| Eps Diluted restated | Q3 2025 · Dec 31, 2024 | −$2.71 |
| Eps Basic | Q3 2025 · Dec 31, 2025 | $0.05 |
| Eps Basic | Q3 2025 · Dec 31, 2025 | −$0.48 |
| Eps Basic restated | Q3 2025 · Dec 31, 2024 | −$0.46 |
| Eps Basic restated | Q3 2025 · Dec 31, 2024 | −$2.71 |
| Sga Expense | Q3 2025 · Dec 31, 2025 | $3.39M |
| Sga Expense | Q3 2025 · Dec 31, 2025 | $11.49M |
| Sga Expense | Q3 2025 · Dec 31, 2024 | $3.86M |
| Sga Expense | Q3 2025 · Dec 31, 2024 | $12.97M |
| Rd Expense | Q3 2025 · Dec 31, 2025 | $237K |
| Rd Expense | Q3 2025 · Dec 31, 2025 | $676K |
| Rd Expense | Q3 2025 · Dec 31, 2024 | $287K |
| Rd Expense | Q3 2025 · Dec 31, 2024 | $840K |
| Net Income | Q3 2025 · Dec 31, 2025 | $160K |
| Net Income | Q3 2025 · Dec 31, 2025 | −$1.67M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$581K |
| Net Income | Q3 2025 · Jun 30, 2025 | −$1.24M |
| Net Income | Q3 2025 · Dec 31, 2024 | −$1.51M |
| Net Income | Q3 2025 · Dec 31, 2024 | −$8.89M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$3.63M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$3.76M |
| Operating Income | Q3 2025 · Dec 31, 2025 | $386K |
| Operating Income | Q3 2025 · Dec 31, 2025 | −$869K |
| Operating Income | Q3 2025 · Dec 31, 2024 | −$1.25M |
| Operating Income | Q3 2025 · Dec 31, 2024 | −$7.95M |
| Gross Profit | Q3 2025 · Dec 31, 2025 | $6.51M |
| Gross Profit | Q3 2025 · Dec 31, 2025 | $18.59M |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $5.75M |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $14.5M |
| Revenue | Q3 2025 · Dec 31, 2025 | $21.09M |
| Revenue | Q3 2025 · Dec 31, 2025 | $60.58M |
| Revenue | Q3 2025 · Dec 31, 2024 | $19.58M |
| Revenue | Q3 2025 · Dec 31, 2024 | $58.85M |